Six-Month Protection: Lenacapavir Injection Could Transform HIV Prevention
In a groundbreaking development for HIV prevention, the efficacy and safety of a six-monthly injection containing the antiretroviral drug lenacapavir have been confirmed through two pivotal studies. This innovative jab represents a significant advancement in the fight against HIV, providing a new option for individuals